3D model is for representation purpose only.
.
.
![]() |
![]() |
![]() |
![]() |
![]() |
|---|---|---|---|---|
| XEFFX | Methotrexate |
| Identification | |
|---|---|
| ConjuPepDB ID | cpd00850 |
| Smiles | |
| Inchi Key | InChIKey=OMLLBDRDSBTKSO-ZYADHFCISA-N |
| Molecular weight | 904.434 |
| Molecular formula | C46H56N12O8 |
| Chemical name | Peptide information |
| Sequence (one letter) | XEFFX |
| Length | 5 |
| Peptide name | tripeptide |
| External ID | |
|---|---|
| CAS number | 864282-05-3 |
| Other information | |
|---|---|
| Application | Anti-inflamatory therapy, osteoarthritis |
| Conjugate type | amide |
| Linker | no |
| Small molecule | Methotrexate |
| Small molecule CAS | 59-05-2 |
| Small molecule structure | |
| Structure method | 1H-NMR |
| NMR solvent | DMSO-d6 |
| Calculated properties | |
|---|---|
| LogP | 1.73049 |
| Rotatable bonds | 25 |
| H bond donor | 7 |
| H bond acceptor | 14 |
| Polar surface area (PSA) | 301.86000 |
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI |
Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis | 2010 | Homma, Akie; Sato, Haruhiko; Tamura, Tatsuya; Okamachi, Akira; Emura, Takashi; Ishizawa, Takenori; Kato, Tatsuya; Matsuura, Tetsu; Sato, Shigeo; Higuchi, Yoshinobu; Watanabe, Tomoyuki; Kitamura, Hidetomo; Asanuma, Kentaro; Yamazaki, Tadao; Ikemi, Masahisa; Kitagawa, Hironoshin; Morikawa, Tadashi; Ikeya, Hitoshi; Maeda, Kazuaki; Takahashi, Koichi; Nohmi, Kenji; Izutani, Noriyuki; Kanda, Makoto; Suzuki, Ryohchi | Bioorganic & Medicinal Chemistry | ||